Research Paper Volume 15, Issue 17 pp 8664—8691
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
Figure 4. Co-expression of KIAA1429 and immune-related genes. *P < 0.05, **P < 0.01, ***P < 0.001.